ATE411280T1 - Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege - Google Patents

Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege

Info

Publication number: ATE411280T1
Authority: AT; Austria
Prior art keywords: respiratory disorders; treatment; acid derivatives; phenoxyacetic acid; disorders
Prior art date: 2003-04-07

Application number

AT04726045T

Other languages

English (en)

Inventor

Garry Pairaudeau

Rukhsana Mohammed

Stephen Thom

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-07

Filing date

2004-04-06

Publication date

2008-10-15

2004-04-06 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2008-10-15 Application granted granted Critical

2008-10-15 Publication of ATE411280T1 publication Critical patent/ATE411280T1/de

Links

LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical class OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 title abstract 2
208000023504 respiratory system disease Diseases 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)

AT04726045T 2003-04-07 2004-04-06 Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege ATE411280T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0301009A SE0301009D0 (sv)	2003-04-07	2003-04-07	Novel compounds

Publications (1)

Publication Number	Publication Date
ATE411280T1 true ATE411280T1 (de)	2008-10-15

Family

ID=20290948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04726045T ATE411280T1 (de)	2003-04-07	2004-04-06	Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege

Country Status (8)

Country	Link
US (1)	US20060211765A1 (de)
EP (1)	EP1636175B1 (de)
JP (1)	JP4588018B2 (de)
AT (1)	ATE411280T1 (de)
DE (1)	DE602004017174D1 (de)
ES (1)	ES2314389T3 (de)
SE (1)	SE0301009D0 (de)
WO (1)	WO2004089884A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0301010D0 (sv) *	2003-04-07	2003-04-07	Astrazeneca Ab	Novel compounds
SA04250253B1 (ar)	2003-08-21	2009-11-10	استرازينيكا ايه بي	احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
RU2387652C2 (ru)	2004-03-11	2010-04-27	Актелион Фармасьютиклз Лтд	Производные тетрагидропиридоиндола
BRPI0510043A (pt) *	2004-04-20	2007-10-16	Pfizer	método de tratamento de dor neuropática usando antagonista de receptor crth2
GB0409921D0 (en) *	2004-05-04	2004-06-09	Novartis Ag	Organic compounds
GB0415320D0 (en) *	2004-07-08	2004-08-11	Astrazeneca Ab	Novel compounds
GB0418830D0 (en)	2004-08-24	2004-09-22	Astrazeneca Ab	Novel compounds
GB0422057D0 (en) *	2004-10-05	2004-11-03	Astrazeneca Ab	Novel compounds
JP5208510B2 (ja)	2004-11-23	2013-06-12	アストラゼネカ・アクチエボラーグ	呼吸器疾患の処置に有用なフェノキシ酢酸誘導体
KR101289995B1 (ko)	2005-09-27	2013-07-26	시오노기 앤드 컴파니, 리미티드	Ｐｇｄ2 수용체 길항제 활성을 갖는 설폰아마이드 유도체
JP5155171B2 (ja)	2005-10-06	2013-02-27	アストラゼネカ・アクチエボラーグ	新規化合物
RU2424229C2 (ru) *	2005-10-06	2011-07-20	Астразенека Аб	Производные бифенилоксиуксусной кислоты, их применение для изготовления лекарственного средства и промежуточные соединения
TW200745003A (en) *	2005-10-06	2007-12-16	Astrazeneca Ab	Novel compounds
GB0520324D0 (en) *	2005-10-06	2005-11-16	Astrazeneca Ab	Novel compounds
US20080255150A1 (en) *	2005-11-05	2008-10-16	Astrazeneca Ab	Novel Compounds
WO2007062678A1 (en) *	2005-11-29	2007-06-07	7Tm Pharma A/S	Phenoxyacetic acid derivatives as crth2 receptor ligands
EP1963259B1 (de) *	2005-12-15	2012-02-15	AstraZeneca AB	Substituierte diphenylether, -amine, -sulfide und methane zur behandlung von atemwegserkrankungen
UA100983C2 (ru) *	2007-07-05	2013-02-25	Астразенека Аб	Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
CA2707785C (en)	2007-12-14	2015-11-03	Pulmagen Therapeutics (Asthma) Limited	Indoles and their therapeutic use
WO2009089192A1 (en) *	2008-01-07	2009-07-16	Ligand Pharmaceuticals Inc.	2-phenyl phenoxyacetic acids useful for treating inflammatory disorders
WO2009151910A2 (en) *	2008-05-25	2009-12-17	Wyeth	Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
WO2010102154A2 (en) *	2009-03-05	2010-09-10	Ligand Pharmaceuticals Incorporated	Biaryl oxyacetic acid compounds
JP5800898B2 (ja)	2010-07-05	2015-10-28	アクテリオンファーマシューティカルズリミテッドＡｃｔｅｌｉｏｎＰｈａｒｍａｃｅｕｔｉｃａｌｓＬｔｄ	１−フェニル−置換ヘテロシクリル誘導体及びプロスタグランジンｄ２受容体調節剤としてのそれらの使用
EP2457900A1 (de)	2010-11-25	2012-05-30	Almirall, S.A.	Neue Pyrazolderivate mit CRTH2-antagonistischem Verhalten
EP2526945A1 (de)	2011-05-25	2012-11-28	Almirall, S.A.	Neue CRTH2-Antagonisten
EP2548876A1 (de)	2011-07-18	2013-01-23	Almirall, S.A.	Neue CRTH2-Antagonisten
EP2548863A1 (de)	2011-07-18	2013-01-23	Almirall, S.A.	Neue CRTH2-Antagonisten
SG11201402796SA (en)	2011-12-16	2014-06-27	Atopix Therapeutics Ltd	Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
RU2014129613A (ru)	2011-12-21	2016-02-10	Актелион Фармасьютиклз Лтд	Гетероциклильные производные и их применение в качестве модуляторов рецептора простагландина d2
US9169270B2 (en)	2012-07-05	2015-10-27	Actelion Pharmaceuticals Ltd.	1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
AU2014364327B2 (en) *	2013-12-10	2021-03-04	The Regents Of The University Of California	Differential diagnosis of liver disease
DK3307262T3 (da)	2015-06-15	2021-08-09	Nmd Pharma As	Forbindelser til anvendelse ved behandling af neuromuskulære lidelser
US11730714B2 (en)	2017-12-14	2023-08-22	Nmd Pharma A/S	Compounds for the treatment of neuromuscular disorders
US11591284B2 (en)	2017-12-14	2023-02-28	Nmd Pharma A/S	Compounds for the treatment of neuromuscular disorders
TWI794369B (zh)	2017-12-14	2023-03-01	丹麥商Ｎｍｄ藥品公司	用於治療神經肌肉病症的化合物
US10385028B2 (en)	2017-12-14	2019-08-20	Nmd Pharma A/S	Compounds for the treatment of neuromuscular disorders
US11147788B2 (en)	2017-12-14	2021-10-19	Nmd Pharma A/S	Compounds for the treatment of neuromuscular disorders
TW201927738A (zh)	2017-12-14	2019-07-16	丹麥商Ｎｍｄ藥品公司	用於治療神經肌肉病症的化合物
TWI780281B (zh)	2017-12-14	2022-10-11	丹麥商Ｎｍｄ藥品公司	用於治療神經肌肉病症的化合物
US12415771B2 (en)	2019-06-19	2025-09-16	Nmd Pharma A/S	Compounds for the treatment of neuromuscular disorders

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3278524A (en) *	1962-03-13	1966-10-11	Beecham Group Ltd	Penicillins and their production
BE790679A (fr) *	1971-11-03	1973-04-27	Ici Ltd	Derives de l'indole
JPS5239888B2 (de) *	1973-05-28	1977-10-07
US4670566A (en) *	1979-07-12	1987-06-02	A. H. Robins Company, Incorporated	3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones
US5006542A (en) *	1988-10-31	1991-04-09	E. R. Squibb & Sons, Inc.	Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use
US5145790A (en) *	1990-05-04	1992-09-08	Abbott Laboratories	Reagents and method for detecting polychlorinated biphenyls
CA2090283A1 (en) *	1992-02-28	1993-08-29	Nobuyuki Hamanaka	Phenoxyacetic acid derivatives
JPH06313995A (ja) *	1993-04-28	1994-11-08	Hodogaya Chem Co Ltd	静電荷像現像用トナー
US5942532A (en) *	1997-09-05	1999-08-24	Ortho Pharmaceutical Corporation	2-substituted phenyl-benzimidazole antibacterial agents
KR100340273B1 (ko) *	1997-10-14	2002-06-14	야마모토 카즈모토	비페닐-5-알칸산 유도체 및 이의 용도
JP2002516305A (ja) *	1998-05-12	2002-06-04	アメリカン・ホーム・プロダクツ・コーポレイション	インスリン抵抗性および高血糖症の治療に有用な２，３，５−置換ビフェニル
AU7073400A (en) *	1999-08-27	2001-03-26	Eli Lilly And Company	Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
WO2001060807A1 (en) *	2000-02-18	2001-08-23	Merck & Co. Inc.	Aryloxyacetic acids for diabetes and lipid disorders
US6699997B2 (en) *	2000-06-28	2004-03-02	Teva Pharmaceutical Industries Ltd.	Carvedilol
US6878522B2 (en) *	2000-07-07	2005-04-12	Baiyong Li	Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
US20040097555A1 (en) *	2000-12-26	2004-05-20	Shinegori Ohkawa	Concomitant drugs
BR0210391A (pt) *	2001-06-12	2004-06-15	Elan Pharm Inc	Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
NZ535603A (en) *	2002-03-20	2007-10-26	Metabolex Inc	Substituted phenylacetic acids
AU2003297398B2 (en) *	2002-12-20	2009-09-24	Amgen Inc.	Asthma and allergic inflammation modulators
AU2004232682B2 (en) *	2003-03-28	2006-12-07	Eli Lilly And Company	Isoquinoline-5-sulfonic acid amides as inhibitors of Akt (protein kinase B)
SE0301010D0 (sv) *	2003-04-07	2003-04-07	Astrazeneca Ab	Novel compounds
SA04250253B1 (ar) *	2003-08-21	2009-11-10	استرازينيكا ايه بي	احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
US7166738B2 (en) *	2004-04-23	2007-01-23	Roche Palo Alto Llc	Non-nucleoside reverse transcriptase inhibitors
GB0415320D0 (en) *	2004-07-08	2004-08-11	Astrazeneca Ab	Novel compounds
GB0418830D0 (en) *	2004-08-24	2004-09-22	Astrazeneca Ab	Novel compounds
GB0422057D0 (en) *	2004-10-05	2004-11-03	Astrazeneca Ab	Novel compounds
JP5208510B2 (ja) *	2004-11-23	2013-06-12	アストラゼネカ・アクチエボラーグ	呼吸器疾患の処置に有用なフェノキシ酢酸誘導体
JP5155171B2 (ja) *	2005-10-06	2013-02-27	アストラゼネカ・アクチエボラーグ	新規化合物
TW200745003A (en) *	2005-10-06	2007-12-16	Astrazeneca Ab	Novel compounds
US20080255150A1 (en) *	2005-11-05	2008-10-16	Astrazeneca Ab	Novel Compounds
EP1963259B1 (de) *	2005-12-15	2012-02-15	AstraZeneca AB	Substituierte diphenylether, -amine, -sulfide und methane zur behandlung von atemwegserkrankungen
UA100983C2 (ru) *	2007-07-05	2013-02-25	Астразенека Аб	Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты

2003
- 2003-04-07 SE SE0301009A patent/SE0301009D0/xx unknown
2004
- 2004-04-06 DE DE602004017174T patent/DE602004017174D1/de not_active Expired - Lifetime
- 2004-04-06 JP JP2006508006A patent/JP4588018B2/ja not_active Expired - Fee Related
- 2004-04-06 ES ES04726045T patent/ES2314389T3/es not_active Expired - Lifetime
- 2004-04-06 EP EP04726045A patent/EP1636175B1/de not_active Expired - Lifetime
- 2004-04-06 US US10/552,082 patent/US20060211765A1/en not_active Abandoned
- 2004-04-06 WO PCT/SE2004/000534 patent/WO2004089884A1/en not_active Ceased
- 2004-04-06 AT AT04726045T patent/ATE411280T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1636175A1 (de)	2006-03-22
WO2004089884A1 (en)	2004-10-21
SE0301009D0 (sv)	2003-04-07
JP2006522117A (ja)	2006-09-28
JP4588018B2 (ja)	2010-11-24
ES2314389T3 (es)	2009-03-16
US20060211765A1 (en)	2006-09-21
DE602004017174D1 (de)	2008-11-27
EP1636175B1 (de)	2008-10-15

Legal Events

Date	Code	Title	Description
2009-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE411280T1 (de)	2008-10-15	Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
SE0301010D0 (sv)	2003-04-07	Novel compounds
MY142029A (en)	2010-08-16	Phenoxyacetic acid derivatives
CY1110812T1 (el)	2015-06-10	Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων
DE60225556D1 (de)	2008-04-24	Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
MXPA03011484A (es)	2004-03-18	Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
EA200602191A1 (ru)	2007-06-29	5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
TW200612892A (en)	2006-05-01	Novel compounds
ATE421322T1 (de)	2009-02-15	Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege
CY1112115T1 (el)	2015-11-04	Παραγωγα φαινοξυοξικου οξεος χρησιμα για τη θεραπευτικη αντιμετωπιση ασθενειων του αναπνευστικου
DE60325379D1 (de)	2009-01-29	Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen
EA201071045A1 (ru)	2011-02-28	Соединения оксадиазоантрацена для лечения диабета
CL2003002683A1 (es)	2005-04-08	Enantiomeros s de compuestos derivados del acido (2s)-3-4(-{2-amino-2-oxoetoxi}fenil)-2-etoxipropanoico; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos de lipidos,
EP1784388B8 (de)	2010-05-19	Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE365720T1 (de)	2007-07-15	Agonisten von beta-adrenorezeptoren
UA84048C2 (ru)	2008-09-10	Производные сульфонамида для лечения заболеваний, способ их получения (варианты), фармацевтическая композиция на их основе
ATE538651T1 (de)	2012-01-15	Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
ATE461697T1 (de)	2010-04-15	Phospholipidderivate von valproinsäure und ihre kombinationen
ATE432278T1 (de)	2009-06-15	Verbindungen zur behandlung von krankheiten
ATE439833T1 (de)	2009-09-15	Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten
DE502005008971D1 (de)	2010-03-25	Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht
ATE432936T1 (de)	2009-06-15	Imidazotriazin verbindungen zur behandlung von krebserkrankungen
DE60027127D1 (de)	2006-05-18	Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
BRPI0508927A (pt)	2007-08-14	compostos úteis para o tratamento de doenças
NO20063859L (no)	2006-08-29	Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter